Hospital Pharmacy Europe - Metabolic disorders,

Click here

Thursday 23 May 2013 Register Login

You are here:

Suppliers Guide

New neurology product

Hospital Pharmacy Europe is assisting with a survey on messaging for a new neurology product. Click here

LATEST ISSUE

Contamination control and preparation of anticancer drugs, medicines reconciliation, Ruconest drug evaluation, ivacaftor for cystic fibrosis , oxycodone-naloxone prolonged-release tablets, IV chemotherapy, capsaicin in the treatment of severe neuropathic pain, alitretinoin in severe chronic hand eczema, Zyclara for actinic keratoses

Pharmacy Zone: Metabolic disorders

Magazine	Sponsored content
News	Video

Thu 8 Nov
2012

Albireo granted orphan drug designation for A4250
Albireo AB (Gothenburg, Sweden; “Albireo”), a biopharmaceutical company specialising in gastroenterology, today...

Tue 24 Apr
2012

CHMP backs Rienso for iron-deficiency anaemia
The positive opinion relates to iron-deficiency anaemia in patients with chronic kidney disease

Mon 28 Nov
2011

New legislations for diabetic drivers
Recurrent severe hypoglycaemia, even during sleep, labelled 'significant predictor' of crash risk

Thu 3 Nov
2011

Kidney drug trial stopped after negative results
Sulodexide not effective in preventing kidney failure in diabetes patients, study finds

Mon 19 Sep
2011

Linagliptin efficacious for type 2 diabetes
DPP-4 inhibitor studies also demonstrated meaningful glycaemic control

Thu 15 Sep
2011

Glucose biosensor for diabetes 'shows high accuracy'
Fully-implanted continuous glucose sensor for use with type-1 diabetes

Wed 14 Sep
2011

'Injectables increase diabetes treatment satisfaction'
Victoza® injection shows promise as replacement for oral therapy with sitagliptin

Wed 29 Jun
2011

EMA recommends approval of linagliptin for type 2 diabetes
The EMA gives a positive opinion on linagliptin 5mg film-coated tablets for type 2 diabetes

Tue 28 Jun
2011

Pharmacists aid in combat of non-communicable disease
Commonwealth Pharmacists' Association commits to combating non-communicable diseases in Durban Declaration

Tue 28 Jun
2011

Connexios present preclinical data on CNX-011-67
Connexios Life Sciences announces preclinical data on CNX-011-67 that suggests value for early therapy

Mon 27 Jun
2011

Linagliptin effective as glimepiride, fewer CV events
Two-year Phase III study confirms linagliptin has significant efficacy and good tolerability in combination therapy with metformin

Mon 27 Jun
2011

High-dose statins may raise risk of diabetes
High-dose statin therapy may increase the likelihood of developing new-onset diabetes, research suggests.

Mon 20 Jun
2011

Review of pioglitazone-containing medicines continues
Use of pioglitazone-containing medicines suspended in France due to Europe-wide review

Mon 16 May
2011

NICE makes diabetes recommendations
Pharmacists in England should advise consumers to fight off type 2 diabetes with exercise

Web design, hosting and programming by ModeZero